Combination strategies for checkpoint inhibition: Current practices and perspectives

被引：3
作者：
Dussart, Chloe [1 ]
Decaux-Tramoni, Baptiste [1 ]
Quesada, Stanislas [2 ]
Thomas, Quentin Dominique [1 ,2 ]
Benzerouale, Ouail [1 ]
Nicolas, Emanuel [1 ,3 ]
Fiteni, Frederic [1 ,3 ]
机构：
[1] CHU Nimes, Serv oncol med, 4 rue Prof-Robert-Debre, F-30900 Nimes, France
[2] Inst reg Canc Montpellier, Dept oncol med, F-34298 Montpellier 5, France
[3] Univ Montpellier, Inst Desbrest epidemiol & Sante publ, Inserm UMR 1302, F-34090 Montpellier, France
来源：
BULLETIN DU CANCER | 2023年 / 110卷 / 08期
关键词：
Immune checkpoint; inhibitor; Immunotherapy; Anti-CTLA-4; Anti-PD-1; L1; Anti-LAG-3; CANCER; NIVOLUMAB;
D O I：
10.1016/j.bulcan.2023.03.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：790 / 801
页数：12
相关论文
共 56 条
  • [51] Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]
  • [52] Villarroel-Espindola F, 2018, CLIN CANCER RES, V24
  • [53] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [54] Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
    Woo, Seng-Ryong
    Turnis, Meghan E.
    Goldberg, Monica V.
    Bankoti, Jaishree
    Selby, Mark
    Nirschl, Christopher J.
    Bettini, Matthew L.
    Gravano, David M.
    Vogel, Peter
    Liu, Chih Long
    Tangsombatvisit, Stephanie
    Grosso, Joseph F.
    Netto, George
    Smeltzer, Matthew P.
    Chaux, Alcides
    Utz, Paul J.
    Workman, Creg J.
    Pardoll, Drew M.
    Korman, Alan J.
    Drake, Charles G.
    Vignali, Dario A. A.
    [J]. CANCER RESEARCH, 2012, 72 (04) : 917 - 927
  • [55] Yap TA, 2021, CANCER DISCOV, V11
  • [56] Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
    Yau, Thomas
    Kang, Yoon-Koo
    Kim, Tae-You
    El-Khoueiry, Anthony B.
    Santoro, Armando
    Sangro, Bruno
    Melero, Ignacio
    Kudo, Masatoshi
    Hou, Ming-Mo
    Matilla, Ana
    Tovoli, Francesco
    Knox, Jennifer J.
    He, Aiwu Ruth
    El-Rayes, Bassel F.
    Acosta-Rivera, Mirelis
    Lim, Ho-Yeong
    Neely, Jaclyn
    Shen, Yun
    Wisniewski, Tami
    Anderson, Jeffrey
    Hsu, Chiun
    [J]. JAMA ONCOLOGY, 2020, 6 (11)
123456